Hepatitis

Hepatitis C

Highlight

WHO Progress report on access to hepatitis C treatment - Focus on overcoming barriers in low- and middle-income countries, March 2018

Progress report on access to hepatitis C treatment
March 2018
Increased access to highly effective direct-acting antivirals (DAAs) for the treatment of infection with the hepatitis C virus (HCV) is revolutionizing the prospect of ending HCV epidemics. Globally, the number of people who initiated DAA-based treatment for HCV rose between 2015 and 2016, from approximately 1 million to 1.5 million.


Latest updates

Key facts

Related links

Journal articles